References
- Yang CC, Hu HS, Wu RH, et al. A novel dengue virus inhibitor, BP13944, discovered by high-throughput screening with dengue virus replicon cells selects for resistance in the viral NS2B/NS3 protease. Antimicrob Agent Chemother. 2014;58:110–119.
- Ng L-C, Chem Y, Koo C, et al. Dengue outbreaks in Singapore and Malaysia caused by different viral strains. Am J Trop Med Hyg. 2015;92:1150–1155.
- Sarala N, Paknikar SS. Papaya extract to treat dengue: a novel therapeutic option. Ann Med Health Sci Res. 2014;4:320–324.
- Simmons CP, Farrar JJ, Nguyen VV, et al. Dengue. N Engl J Med. 2012;366:1423–1432.
- Chambers TJ, Hahn CS, Galler R, et al. Flavivirus genome organization, expression, and replication. Annu Rev Microbiol. 1990;44:649–688.
- Yang CC, Hsieh YC, Lee SJ, et al. Novel dengue virus-specific NS2B/NS3 protease inhibitor, BP2109, discovered by a high-throughput screening assay. Antimicrob Agent Chemother. 2011;55:231–233.
- Niyomrattanakit P, Winoyanuwattikun P, Chanprapaph S, et al. Identification of residues in the dengue virus type 2 NS2B cofactor that are critical for NS3 protease activation. J Virol. 2004;78:13708–13716.
- Rothan HA, Abdulrahman AY, Sasikumer PG, et al. Protegrin-1 inhibits dengue NS2B-NS3 serine protease and viral replication in MK2 cells. J Biomed Biotechnol. 2012;2012:1251482.
- Teixeira RR, Pereira WL, Oliveira AF, et al. Natural products as source of potential dengue antivirals. Molecules. 2014;19:8151–8176.
- Szymanski P, Markowicz M, Mikiciuk-Olasik E. Adaptation of high-throughput screening in drug discovery toxicological screening test. Int Mol Sci. 2012;13:427–452.
- Qing M, Liu W, Yuan Z, et al. A high-throughput assay using dengue-1 virus-like particles for drug discovery. Antivir Res. 2010;86:163–171.
- Johnston PA, Phillips J, Shun TY, et al. HTS identifies novel and specific uncompetitive inhibitors of the two-component NS2B-NS3 proteinase of West Nile virus. Assay Drug Dev Technol. 2007;5:737–750.
- Heh CH, Othman R, Buckle MJC, et al. 2013. Rational discovery of dengue type 2 non-competitive inhibitors. Chem Biol Drug Des. 2013;82:1–11.
- Kawamura F, Ramle SFM, Sulaiman O, et al. Antioxidant and antifungal activities of extracts selected hardwood species of Malaysian timber. Eur J Wood Prod. 2011;69:207–212.
- Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55–63.
- Mohamed AA, Ali SI, El-Baz FK. Antioxidant and antibacterial activities of crude extracts and essential oils of Syzygium cumini leaves. PLoS ONE. 2013;8:60269.
- Bligh EG, Dyer WJ. A rapid method for total lipid extraction and purification. J Biochem Physiol. 1959;37:911–917.
- Kadir SLA, Yaakob YH. Potential anti-dengue medicinal plants: a review: J Nat Med. 2013;67:677–689.
- Ravi K, Ramachandran B, Subramanian S. Protective effect of Eugenia jambolana seed kernel on tissue antioxidants in streptozotocin induced diabetic rats. Biol Pharm Bull. 2004;27:1212–1217.
- Santoyo S, Plaza M, Jaime L, et al. Pressurized liquids as an alternative green process to extract antiviral agents from Himanthalia elongate. J Appl Phycol. 2011;23:909–917.
- Patharakorn T, Arpornsuwan T, Wetprasit N, et al. Antibacterial activity and cytotoxicity of the leaf of Morus rotunbiloba Koidz. J Med Plants Res. 2010;4:837–843.
- Aleksic V, Knezevic P. Antimicrobial and antioxidative activity of extracts and essential oils of Myrtus communis L. J Microb Res. 2014;169:247–251.
- Djilani A, Dicko A. Nutrition, well-being and health. Croatia: InTech; 2012. Bouayed J, editor. The therapeutic benefits of essential oils; p. 155–178.
- Samy MN, Sugimoto S, Matsunami K, et al. One new flavonoid xyloside and one new natural triterpene rhamnoside from the leaves of Syzygium grande. J Phytochem Lett. 2014;10:86–90.
- Memon AH, Ismail Z, Al-Suede FS, et al. Isolation, characterization, crystal structure elucidation of two flavanones and simultaneous RP-HPLC determination of five major compounds from Syzygium campanulatum Korth. Molecules. 2015;20:14212–14233.
- Jassim SAA, Naji MA. Novel antiviral agents: a medicinal plant perspective. J Appl Microbiol. 2003;95:412–427.
- Qadir I, Abbas K, Tahir M, et al. Review: dengue fever: natural management. Pak J Pharm Sci. 2015;28:647–655.
- Campos MI, Vieira WDA, Campos CN, et al. Atorvastatin and trans-caryophyllene for the prevention of leukopenia in an experimental chemotherapy model in Wistar rats. Mol Clin Oncol. 2015;3:825–828.